NSEUpdates3 Jul 2026 · 3 Jul 2026, 03:48 pm

Updates

Shilpa Medicare Limited · SHILPAMED

✦ AI SummaryResults

Shilpa Medicare Limited has announced its audited financial results for the fourth quarter and financial year ended March 31, 2026, along with the appointment of cost auditors and internal auditors, and other corporate updates.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shilpa Medicare Limited has informed the Exchange regarding 'Machine Readable copy of Financial Results '.

Attachments (1)

📄

SHILPAMED_03072026154440_SML_outcome.pdf

pdf

Download →
View document text
L Shi/pa Medicare Limited I Innovating for Corporate & Admin Office: . . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road, Raichur 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 22May 2026 Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5" Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Scrip Code: BSE - 530549/ Stock Symbol: NSE SHILPAMED Dear Sir/ Ma'am, Sub: Outcome of the Board Meeting Ref: Regulation 30,33 & 43 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject, we hereby wish to inform you that the Board at its meeting held today, i.e., on 22 May 2026, which commenced at 12.25 P.M and concluded at 2.4 0 P.M has inter alia considered and approved the following: 1) Financials: (a) Audited financial statements (Standalone & Consolidated) for the financial year ended 31 March 2026 together with statement of assets and liabilities, statement of cash flows along with the Auditors' Report with unmodified opinion. (b) Audited financial results (Standalone & Consolidated) for the Fourth quarter and financial year ended31 March 2026. (c) A declaration to the effect that the Auditors have given an unmodified opinion on the Audited financial statements (Standalone & Consolidated) for the financial year ended 31 March 2026. 2) The Board has recommended a final dividend of Re. 0.60/- (60%) per equity share of face value of Re. 1/- each for FY2025-26. The final dividend, if approved by the members atthe ensuing Annual General Meeting, shall be paid within the statutory timelines prescribed under applicable laws. 3) Appointment of M/s. V.J.Talati & Co., Cost Accountants as Cost Auditors of the Company for the FY 2026-27. 4) Appointment of M/s ANEJA ASSOClATES . as Internal Auditors of the Company for FY2026- 27. Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are annexed herewith. L Shi/pa Medicare Limited I Innovating for Corporate & Admin Office: . . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road, Raichur 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 5) Shifting of registered office from #12-6-214/A1, Hyderabad Road, Raichur, Karnataka, India 584135 (State of Karnataka) to State of Maharashtra and to alter the situation clause of the memorandum of association, subject to the approval of members (by way of Postal Ballot) and other authorities, while retaining the Statutory books and registers at #12-6-214/A1, Hyderabad Road, Raichur, Karnataka, India 584135. 6) Notice of Postal Ballot for Shifting of registered office from state of Karnataka to State of Maharashtra and to alter the situation clause of the memorandum of association, subject to the approval of members. 7) Appointment of Mr. Santosh Kumar Gunemoni (M. No: A60103) Practicing Company Secretary, VCAN & Associatesto act as Scrutinizer for the process of Postal Ballot. 8) Shilpa Pharma Lifesciences Limited ("SPL") , Shilpa Biologicals Pvt Ltd ("SBPL"), Shilpa Biocare Pvt Ltd ("Biocare") - wholly owned subsidiaries of Shilpa Medicare Limited, to make an equity investment of 28% in Neo Green Power Project Private Limited. Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are annexed herewith. 9) Shifting of registered office of following Wholly Owned Subsidiaries: a. Shilpa Pharma Lifesciences Limited b. Shilpa Biologicals Private Limited c. Shilpa Biocare Private Limited d. SampraHoldings Private Limited (formerly knownas Vegil Labs Private Limited) from the State of Karnataka to State of Maharashtra. This document ismade available on the website of the Company at https://www.vbshilpa.com/financial- results.php. For Shilpa Medicare Limited, u 1wary TD ii wgi at ,a yll y signed by Ritu Datec2026.05.2214,47,45 +05'30' Ritu Tiwary Company Secretary & Compliance Officer L Shi/pa Medicare Limited I Innovating for Corporate & Admin Office: . . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road, Raichur 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026. Appointment of Cost Auditor 1 Name M/s. V J Talati & Co 2 Reason for change viz., appointment, re- Appointment appointment, resignation, removal, death or otherwise 3 Date of Appointment/re-appointment/cessation May 22, 2026 & term of appointment or reappointment Term: for FY2026-2027 4 Brief Profile (in case of appointment) V. J. TALATI & CO. is a renowned firm with extensive experience in cost auditing and management consultancy across various industries, including Rubber, Textile, Chemicals, Petrochemicals, Cement, Sugar, Steel, and more. The firm specializes in cost audit services, ensuring compliance with statutory regulations, maintaining records, and representing clients before government authorities. They also offer expertise in implementing costing systems, stock-taking, and valuation processes. In addition, V. J. TALATI & CO provides ERP consultancy, focusing on costing and inventory modules. The firm excels in management consultancy, assisting clients with strategic decisions such as "Make or Buy," job work orders, and production continuity. With a strong track record of delivering tailored solutions, V. J. TALATI & CO.is a trusted partner for optimizing cost structures and improving operational efficiency. 5 Disclosure of relationship between directors (in Not Applicable case of appointment of a director) L Shi/pa Medicare Limited I Innovating for Corporate & Admin Office: . . affordable healthcare "Shilpa House",# 12 -6-214/A-1, Hyderabad Road, Raichur 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026. Appointment of Internal Auditor Sl.no Details of event(s) that need to Information of such event(s) be provided 1 Name M/s ANEJA ASSOClATES . 2 Reason for change viz. appointment, reappointment, Appointment resignation, cessation, removal, death or otherwise 3 Date of appointment/ re- 22 May 2026 appointment/cessation (as Term:FY 2026-2027 applicable) & term of appointment/re-appointment; 4 Brief profile (in case of M/s Aneja Assurance Pvt.Ltd, established in 1981, is a appointment) governance, risk and compliance-focused professional services firm with over 300 qualified staff and 40+ years of experience. The firm specializes in integrated internal audits, risk assessment, internal control design and information systems audits, supported by proprietary methodologies such as the Controls Effectiveness Index (CEI) and Robust Controls Index (RCI). With global exposure across 30+ countries and a clientele of more than 250 leading organizations in pharma, manufacturing, BFSI, engineering, logistics, and services, Aneja Associates delivers transparent, standards-aligned assurance reviews that enhance governance processes and shareholder value. 5 Disclosure of relationships -NA between directors (in case of appointment of Director L Shi/pa M [Showing first 8,000 characters — download PDF for full document]